Evidence map›Paper›PMID 35246553›Full record

ArticleScientific reports2022

Temporally dynamic neural correlates of drug cue reactivity, response inhibition, and methamphetamine-related response inhibition in people with methamphetamine use disorder.

Sara Jafakesh, Arshiya Sangchooli, Ardalan Aarabi, Mohammad Sadegh Helfroush, Amirhossein Dakhili, Mohammad Ali Oghabian, Kamran Kazemi, Hamed Ekhtiari

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Sara JafakeshDepartment of Electrical and Electronics Engineering, Shiraz University of Technology, Shiraz, Iran.
Arshiya SangchooliIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Science, Tehran, Iran.
Ardalan AarabiFaculty of Medicine, University of Picardie Jules Verne, Amiens, France.
Mohammad Sadegh HelfroushDepartment of Electrical and Electronics Engineering, Shiraz University of Technology, Shiraz, Iran.
Amirhossein DakhiliMedical Physics Department, Iran University of Medical Sciences, Tehran, Iran.
Mohammad Ali OghabianMedical Physics and Biomedical Engineering Department, Tehran University of Medical Sciences, Tehran, Iran.
Kamran KazemiDepartment of Electrical and Electronics Engineering, Shiraz University of Technology, Shiraz, Iran. kazemi@sutech.ac.ir.
Hamed EkhtiariLaureate Institute for Brain Research (LIBR), 6655 South Yale Ave., Tulsa, OK, 74136, USA. hekhtiari@laureateinstitute.org.
Shiraz University of Technology · IRCentre Hospitalier Universitaire Amiens-Picardie · FRIran University of Medical Sciences · IRLaureate Institute for Brain Research · USTehran University of Medical Sciences · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cue-induced drug craving and disinhibition are two essential components of continued drug use and relapse in substance use disorders. While these phenomena develop and interact across time, the temporal dynamics of their underlying neural activity remain under-investigated. To explore these dynamics, an analysis of time-varying activation was applied to fMRI data from 62 men with methamphetamine use disorder in their first weeks of recovery in an abstinence-based treatment program. Using a mixed block-event, factorial cue-reactivity/Go-NoGo task and a sliding window across the task duration, dynamically-activated regions were identified in three linear mixed effects models (LMEs). Habituation to drug cues across time was observed in the superior temporal gyri, amygdalae, left hippocampus, and right precuneus, while response inhibition was associated with the sensitization of temporally-dynamic activations across many regions of the inhibitory frontoparietal network. Methamphetamine-related response inhibition was associated with temporally-dynamic activity in the parahippocampal gyri and right precuneus (corrected p-value < 0.001), which show a declining cue-reactivity contrast and an increasing response inhibition contrast. Overall, the declining craving-related activations (habituation) and increasing inhibition-associated activations (sensitization) during the task duration suggest the gradual recruitment of response inhibitory processes and a concurrent habituation to drug cues in areas with temporally-dynamic methamphetamine-related response inhibition. Furthermore, temporally dynamic cue-reactivity and response inhibition were correlated with behavioral and clinical measures such as the severity of methamphetamine use and craving, impulsivity and inhibitory task performance. This exploratory study demonstrates the time-variance of the neural activations undergirding cue-reactivity, response inhibition, and response inhibition during exposure to drug cues, and suggests a method to assess this dynamic interplay. Analyses that can capture temporal fluctuations in the neural substrates of drug cue-reactivity and response inhibition may prove useful for biomarker development by revealing the rate and pattern of sensitization and habituation processes, and may inform mixed cue-exposure intervention paradigms which could promote habituation to drug cues and sensitization in inhibitory control regions.

Indexed as

MethamphetamineSubstance-Related DisordersConditioning, PsychologicalCravingCuesHumansMagnetic Resonance ImagingMaleMethamphetamine

Identifiers

PMID35246553
PMCPMC8897423
OpenAlexW4214904291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.